New Drug Delivery Technologies
North America was the largest region in the musculoskeletal disorders drugs market in 2017, accounting for 32% market share. This can be attributed to the high per capita healthcare expenditure and the development of cost effective drugs for musculoskelet
(EMAILWIRE.COM, November 16, 2018 ) Introduction of advanced pain free drug delivery technologies is promoting the use of musculoskeletal drugs. Drug delivery systems refer to methods or processes used to administer a pharmaceutical compound to achieve a therapeutic effect in humans or animals. Drug delivery products such as intrathecal pumps are being used to deliver muscle relaxants such as baclofen directly into spinal cord to provide instant relief. Intra-Articular drug delivery systems are also widely being used to administer medicines to treat arthritis. In addition, these products reduce spasticity symptoms and lower the side effects caused by oral spasticity medications.
THE BUSINESS RESEARCH COMPANY EXPECTS THE GLOBAL MUSCULOSKELETAL DISORDERS DRUGS MARKET TO GROW TO $178 BILLION BY 2021
North America was the largest region in the musculoskeletal disorders drugs market in 2017, accounting for almost one-third of the market share. This can be attributed to the high per capita healthcare expenditure and the development of cost effective drugs for musculoskeletal disorders.
Order the report at https://www.thebusinessresearchcompany.com/report/musculoskeletal-disorders-drugs-global-market-report-2018
According to The Business Research Company’s Consultant, Nitin Gianchandani, topical NSAIDs are being used for treatment of acute musculoskeletal pain in adults. A NSAID penetrates the skin, enters tissues or joints, and reduces processes causing pain in the tissue. It can be used as a gel, cream, spray, or plaster to unbroken skin with musculoskeletal pain. Topical NSAIDs also leads to very low level of drug in the blood as compared to oral drugs, thus, minimizing the risk of harmful effects. In June 2015, medical research organization Cochrane published the results of its clinical trials to compare topical NSAIDs with placebo or other medicines in patients above 16 years with musculoskeletal pain. These results indicate that gel formulations of NSAIDs diclofenac and ketoprofen were more effective in treatment of strain, sprain, or muscle pull, as compared to placebo.
Download a sample of the report at https://www.thebusinessresearchcompany.com/sample.aspx?id=278&type=smp
F. Hoffmann-La Roche Ltd. was the largest company in the musculoskeletal disorders drugs market in 2017, with revenues of $3.2 billion in 2016. Roche’s strategy aims at developing new products by investing in R&D and strategic collaborations and agreements. For example, Bruton’s tyrosine kinase inhibitor (BTKi) and cadherin-11 antibody are being studied in phase II trials for rheumatoid arthritis (RA). In 2016, the company entered into an agreement with Novimmune for NI-0101, an anti-TLR4 investigational medicine, for the treatment of rheumatoid arthritis.
The musculoskeletal disorder drugs market comprises companies that discover, develop, manufacture and distribute medications used in the treatment of musculoskeletal diseases. Musculoskeletal diseases include arthritis, osteoporosis, osteomalacia, carpal tunnel syndrome, tendonitis, rotator cuff tear, muscular dystrophy, myasthenia gravis, lupus erythematosus and others. Some of the major drugs in the market include piroxicam glaxo, dolonex, felden, and piroxicam pfizer. The market numbers within this briefing are restricted to pharmaceutical (drug) treatments and do not cover biologic treatments for these conditions which are included in a separate briefing.
Musculoskeletal Drugs Global Market Report 2018 is a detailed report giving a unique insight into this market. The report is priced at $4000 for an individual user. To use across your office, the price is $6000 and $8000 if you wish to use across a multinational company.
About The Business Research Company
Visit TheBusinessResearchCompany.com, mail info@tbrc.info or call +447443439350 or +918897263534 or +919160996838 for more information on this and many other titles.
The Business Research Company is a market research and intelligence company, which excels in company, market and consumer research.
It has research professionals at its offices in the UK, India and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, chemicals and technology.
The Business Research Company's management has more than 20 years of varied business research experience. They have delivered hundreds of research projects to the senior management of some of the world's largest organizations
Contact Information.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on Linkedin: https://in.linkedin.com/company/the-business-research-company
THE BUSINESS RESEARCH COMPANY EXPECTS THE GLOBAL MUSCULOSKELETAL DISORDERS DRUGS MARKET TO GROW TO $178 BILLION BY 2021
North America was the largest region in the musculoskeletal disorders drugs market in 2017, accounting for almost one-third of the market share. This can be attributed to the high per capita healthcare expenditure and the development of cost effective drugs for musculoskeletal disorders.
Order the report at https://www.thebusinessresearchcompany.com/report/musculoskeletal-disorders-drugs-global-market-report-2018
According to The Business Research Company’s Consultant, Nitin Gianchandani, topical NSAIDs are being used for treatment of acute musculoskeletal pain in adults. A NSAID penetrates the skin, enters tissues or joints, and reduces processes causing pain in the tissue. It can be used as a gel, cream, spray, or plaster to unbroken skin with musculoskeletal pain. Topical NSAIDs also leads to very low level of drug in the blood as compared to oral drugs, thus, minimizing the risk of harmful effects. In June 2015, medical research organization Cochrane published the results of its clinical trials to compare topical NSAIDs with placebo or other medicines in patients above 16 years with musculoskeletal pain. These results indicate that gel formulations of NSAIDs diclofenac and ketoprofen were more effective in treatment of strain, sprain, or muscle pull, as compared to placebo.
Download a sample of the report at https://www.thebusinessresearchcompany.com/sample.aspx?id=278&type=smp
F. Hoffmann-La Roche Ltd. was the largest company in the musculoskeletal disorders drugs market in 2017, with revenues of $3.2 billion in 2016. Roche’s strategy aims at developing new products by investing in R&D and strategic collaborations and agreements. For example, Bruton’s tyrosine kinase inhibitor (BTKi) and cadherin-11 antibody are being studied in phase II trials for rheumatoid arthritis (RA). In 2016, the company entered into an agreement with Novimmune for NI-0101, an anti-TLR4 investigational medicine, for the treatment of rheumatoid arthritis.
The musculoskeletal disorder drugs market comprises companies that discover, develop, manufacture and distribute medications used in the treatment of musculoskeletal diseases. Musculoskeletal diseases include arthritis, osteoporosis, osteomalacia, carpal tunnel syndrome, tendonitis, rotator cuff tear, muscular dystrophy, myasthenia gravis, lupus erythematosus and others. Some of the major drugs in the market include piroxicam glaxo, dolonex, felden, and piroxicam pfizer. The market numbers within this briefing are restricted to pharmaceutical (drug) treatments and do not cover biologic treatments for these conditions which are included in a separate briefing.
Musculoskeletal Drugs Global Market Report 2018 is a detailed report giving a unique insight into this market. The report is priced at $4000 for an individual user. To use across your office, the price is $6000 and $8000 if you wish to use across a multinational company.
About The Business Research Company
Visit TheBusinessResearchCompany.com, mail info@tbrc.info or call +447443439350 or +918897263534 or +919160996838 for more information on this and many other titles.
The Business Research Company is a market research and intelligence company, which excels in company, market and consumer research.
It has research professionals at its offices in the UK, India and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, chemicals and technology.
The Business Research Company's management has more than 20 years of varied business research experience. They have delivered hundreds of research projects to the senior management of some of the world's largest organizations
Contact Information.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on Linkedin: https://in.linkedin.com/company/the-business-research-company
Contact Information:
The Business Research Company
Marketing TBRC
Tel: +91 8897263534
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
The Business Research Company
Marketing TBRC
Tel: +91 8897263534
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results